Legal Notice

 

The Pharmacy Show is sponsored by the pharmaceutical and med tech industries via Grants, Sponsorship, and Exhibition packages. Pharmaceutical companies have solely provided sponsorship through the purchase of exhibition space and/or sponsored speaker sessions with no further input into the arrangements or agenda of the meeting. Sessions delivered with input from our sponsors will always be marked on the programme. A full list of confirmed sponsors for PS25 is available here.

 

 

NEC BIRMINGHAM
11-12 OCTOBER 2026

Loading

Respiratory Tract infections: A new approach

12 Oct 2025
Public Health & Wellbeing Forum
Respiratory Tract infections: A new approach

Respiratory tract infections (RTIs) remain one of the most prevalent health challenges across all age groups, contributing significantly to antibiotic overuse and resistance. In this session, Andrea Vojcikova presents a novel, evidence-based approach to RTI prevention, focusing on immunomodulation through Imunoglukan P4H®, a β-glucan derived from Pleurotus ostreatus. The presentation explores the clinical efficacy, safety, and practical application of this natural compound in children, adults, and patients with chronic or autoimmune conditions. Attendees will gain insights into how this strategy aligns with current clinical guidelines and supports antimicrobial stewardship.

The session also features a short message from elénzia MEDICAL, the UK’s sole distributor of Imunoglukan®, highlighting their commitment to science, efficacy, and wellness. Attendees will learn about elénzia’s upcoming real-world lifestyle study using the Ingredients For Life™ app, designed to expand evidence beyond clinical trials and engage everyday consumers in immune health research.

  • Understand the burden of RTIs and their impact on families and the UK healthcare system.
  • Recognize the limitations of current RTI treatments, including antibiotic overuse and resistance.
  • 3) Explain the immunomodulatory mechanism of Imunoglukan P4H® and its role in enhancing both innate and adaptive immunity.
  • 4) Evaluate clinical and real-world evidence supporting Imunoglukan P4H® in children, adults, and patients with chronic or autoimmune conditions.
  • 5) Apply practical dosing guidelines for preventive and acute use across age groups.
  • 6) Assess the safety profile of Imunoglukan P4H®, including its non-absorption and excellent tolerability.
  • 7) Explore elénzia’s role in bringing Imunoglukan® to the UK market and their Ingredients For Life™ lifestyle study as a model for consumer-led health research.
  • 8) Integrate immunomodulatory strategies into pharmacy practice to support antimicrobial stewardship and patient education.
Speakers
Andrea Vojcikova, Corporate Medical Affairs Manager - Imunoglukan Ltd.
Alexander Pilawski, Lead Nutritional Scientist - elénzia
VIEW THE FULL PROGRAMME

2025 PARTNERS AND SPONSORS

Supported By

Sponsored By

Platinum App Sponsor

Gold App Sponsor

Education Partners

Official Media Partner

Official Digital Partner

Official Publications

Media Partners

Charity Partners

Official Covid & Flu Jab Training

Career Partner